Advanced Search

Economic Impact of Migraine and Other Episodic Headaches in France: Data from the GRIM2000 Study

Contents:

Author Info

  • Andre Pradalier

    (Hopital Louis Mourier, Colombes, France)

  • Jean-Paul Auray

    (Universite Claude Bernard, Lyon, France)

  • Abdelkader El Hasnaoui

    (Laboratoire GlaxoSmithKline, Marly-le-Roi, France)

  • Kazem Alzahouri

    (Universite Claude Bernard, Lyon, France)

  • Jean-Francois Dartigues

    (Universite de Bordeaux II, Bordeaux, France)

  • Gerard Duru

    (Universite Claude Bernard, Lyon, France)

  • Patrick Henry

    (Hopital Pellegrin, Bordeaux, France)

  • Michel Lanteri-Minet

    (Hopital Pasteur, Nice, France)

  • Christian Lucas

    (Hopital Roger Salengro, Lille, France)

  • Guy Chazot

    (Hopital Neurologique, Lyon, France)

  • Anne-Francois Gaudin

    (Laboratoire GlaxoSmithKline, Marly-le-Roi, France)

Registered author(s):

    Abstract

    Background: Migraine is a prevalent and incapacitating condition that affects individuals in the prime of their productive life, thus generating an economic burden for both society and healthcare systems. The direct annual healthcare costs of migraine in France were assessed over 10 years ago, and the current study updates these figures. Objective: The objective of this study was to determine the economic cost (primarily direct costs) of migraine and other episodic headache in France based on a general population survey of headache, the GRIM2000 (Groupe de Researche Interdisciplinaire sur la Migraine). Design: From a representative general population sample of 10 Results: The prevalence of migraine (including migrainous disorder) was determined to be 17%. Total annual direct healthcare costs were estimated to be Conclusions: The direct healthcare costs of migraine do not seem to have risen significantly over the past decade. A small minority of individuals with more severe headaches consume most of the healthcare resources devoted to migraine, while most individuals generate relatively low direct costs. The total annual direct costs in France for migraine are almost 10-fold higher than those of other episodic headache.

    Download Info

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
    File URL: http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-200422150-00003.pdf
    Download Restriction: Pay per view

    File URL: http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200422150-00003.htm
    Download Restriction: Pay per view

    As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

    Bibliographic Info

    Article provided by Springer Healthcare | Adis in its journal PharmacoEconomics.

    Volume (Year): 22 (2004)
    Issue (Month): 15 ()
    Pages: 985-999
    Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
    Handle: RePEc:wkh:phecon:v:22:y:2004:i:15:p:985-999

    Contact details of provider:
    Web page: http://pharmacoeconomics.adisonline.com/

    For corrections or technical questions regarding this item, or to correct its listing, contact: (Dave Dustin).

    Related research

    Keywords: Analgesics; Antimigraines; Cost-of-illness; Headache; Migraine;

    Find related papers by JEL classification:

    References

    No references listed on IDEAS
    You can help add them by filling out this form.

    Citations

    Lists

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    Statistics

    Access and download statistics

    Corrections

    When requesting a correction, please mention this item's handle: RePEc:wkh:phecon:v:22:y:2004:i:15:p:985-999

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dave Dustin).

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.